Aggregated Electronegative Low Density Lipoprotein in Human Plasma Shows a High Tendency toward Phospholipolysis and Particle Fusion*

Aggregation and fusion of lipoproteins trigger subendothelial retention of cholesterol, promoting atherosclerosis. The tendency of a lipoprotein to form fused particles is considered to be related to its atherogenic potential. We aimed to isolate and characterize aggregated and nonaggregated subfractions of LDL from human plasma, paying special attention to particle fusion mechanisms. Aggregated LDL was almost exclusively found in electronegative LDL (LDL(−)), a minor modified LDL subfraction, but not in native LDL (LDL(+)). The main difference between aggregated (agLDL(−)) and nonaggregated LDL(−) (nagLDL(−)) was a 6-fold increased phospholipase C-like activity in agLDL(−). agLDL(−) promoted the aggregation of LDL(+) and nagLDL(−). Lipoprotein fusion induced by α-chymotrypsin proteolysis was monitored by NMR and visualized by transmission electron microscopy. Particle fusion kinetics was much faster in agLDL(−) than in nagLDL(−) or LDL(+). NMR and chromatographic analysis revealed a rapid and massive phospholipid degradation in agLDL(−) but not in nagLDL(−) or LDL(+). Choline-containing phospholipids were extensively degraded, and ceramide, diacylglycerol, monoacylglycerol, and phosphorylcholine were the main products generated, suggesting the involvement of phospholipase C-like activity. The properties of agLDL(−) suggest that this subfraction plays a major role in atherogenesis by triggering lipoprotein fusion and cholesterol accumulation in the arterial wall.

• Publication year

  2010

• Venue

  Journal of Biological Chemistry

• Publication date

  2010-07-29

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1074/jbc.M110.139691PMID 20670941PMCID PMC2952244
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Proteolysis sensitizes LDL particles to phospholipolysis by secretory phospholipase A2 group V and secretory sphingomyelinase

  2010cited by this paper
• Biology of Platelet-activating Factor Acetylhydrolase (PAF-AH, Lipoprotein Associated Phospholipase A2)

  2009cited by this paper
• Proteomic analysis of human low‐density lipoprotein reveals the presence of prenylcysteine lyase, a hydrogen peroxide‐generating enzyme

  2009cited by this paper
• Analytical approaches toward successful human cell metabolome studies by NMR spectroscopy.

  2009cited by this paper
• Novel phospholipolytic activities associated with electronegative low-density lipoprotein are involved in increased self-aggregation.

  2008cited by this paper
• Pro-inflammatory action of LDL(-) on mononuclear cells is counteracted by increased IL10 production.

  2007cited by this paper
• 1H NMR at 800 MHz facilitates detailed phospholipid follow-up during atherogenic modifications in low density lipoproteins.

  2007cited by this paper
• Dynamics of dense electronegative low density lipoproteins and their preferential association with lipoprotein phospholipase A2 Published, JLR Papers in Press, November 13, 2006.

  2007cited by this paper
• Electronegative LDLs from familial hypercholesterolemic patients are physicochemically heterogeneous but uniformly proapoptotic Published, JLR Papers in Press, October 2, 2006.

  2007cited by this paper
• Wide proinflammatory effect of electronegative low-density lipoprotein on human endothelial cells assayed by a protein array.

  2006cited by this paper
• Modulation of angiogenic processes in cultured endothelial cells by low density lipoproteins subfractions from patients with familial hypercholesterolemia.

  2006cited by this paper
• LDL phospholipid hydrolysis produces modified electronegative particles with an unfolded apoB-100 protein Published, JLR Papers in Press, October 16, 2004. DOI 10.1194/jlr.M400306-JLR200

  2005cited by this paper
• Lipoproteomics I: Mapping of proteins in low‐density lipoprotein using two‐dimensional gel electrophoresis and mass spectrometry

  2005cited by this paper
• Beyond cholesterol: the enigma of atherosclerosis revisited

  2004cited by this paper
• Effect of simvastatin in familial hypercholesterolemia on the affinity of electronegative low-density lipoprotein subfractions to the low-density lipoprotein receptor.

  2004cited by this paper
• Electronegative low-density lipoprotein

  2004cited by this paper
• Increased lysophosphatidylcholine and non-esterified fatty acid content in LDL induces chemokine release in endothelial cells. Relationship with electronegative LDL.

  2004cited by this paper
• Impaired binding affinity of electronegative low-density lipoprotein (LDL) to the LDL receptor is related to nonesterified fatty acids and lysophosphatidylcholine content.

  2004cited by this paper
• Platelet‐Activating Factor Acetylhydrolase Is Mainly Associated With Electronegative Low‐Density Lipoprotein Subfraction

  2003cited by this paper
• Electronegative LDL of FH subjects: chemical characterization and induction of chemokine release from human endothelial cells.

  2003cited by this paper
• Density distribution of electronegative LDL in normolipemic and hyperlipemic subjects.

  2002cited by this paper
• Postprandial Oxidative Stress

  2002cited by this paper
• Distinct patterns of lipoproteins with apoB defined by presence of apoE or apoC-III in hypercholesterolemia and hypertriglyceridemia.

  2001cited by this paper
• Altered phospholipid-apoB-100 interactions and generation of extra membrane material in proteolysis-induced fusion of LDL particles.

  2001cited by this paper
• Loss of apoB-100 secondary structure and conformation in hydroperoxide rich, electronegative LDL(-).

  2001cited by this paper
• Effect of glycemic optimization on electronegative low-density lipoprotein in diabetes: relation to nonenzymatic glycosylation and oxidative modification.

  2001cited by this paper
• Electronegative LDL From Normolipemic Subjects Induces IL-8 and Monocyte Chemotactic Protein Secretion by Human Endothelial Cells

  2000cited by this paper
• Oxidative Modification of Low-Density Lipoprotein (LDL) in HD Patients: Role in Electronegative LDL Formation

  2000cited by this paper
• Aggregation, fusion, and vesicle formation of modified low density lipoprotein particles: molecular mechanisms and effects on matrix interactions.

  2000cited by this paper
• Oxidative Cross-linking of ApoB100 and Hemoglobin Results in Low Density Lipoprotein Modification in Blood

  1999cited by this paper
• Detection of low density lipoprotein particle fusion by proton nuclear magnetic resonance spectroscopy.

  1998cited by this paper
• Association of apo B lipoproteins with arterial proteoglycans: pathological significance and molecular basis.

  1998cited by this paper
• Sphingomyelinase Induces Aggregation and Fusion, but Phospholipase A2 Only Aggregation, of Low Density Lipoprotein (LDL) Particles

  1998cited by this paper
• Atherosclerosis is an Inflammatory Disease

  1998cited by this paper
• The response-to-retention hypothesis of atherogenesis reinforced.

  1998cited by this paper
• LDL- is a lipid hydroperoxide-enriched circulating lipoprotein.

  1997cited by this paper
• LDL from aerobically-trained subjects shows higher resistance to oxidative modification than LDL from sedentary subjects.

  1997cited by this paper
• The Yin and Yang of oxidation in the development of the fatty streak. A review based on the 1994 George Lyman Duff Memorial Lecture.

  1996cited by this paper
• Copper-induced LDL peroxidation investigated by 1H-NMR spectroscopy.

  1995cited by this paper
• Altered Susceptibility to in Vitro Oxidation of LDL in LDL Complexes and LDL Aggregates

  1993cited by this paper
• Altered susceptibility to in vitro oxidation of LDL in LDL complexes and LDL aggregates.

  1992cited by this paper
• Application of electron microscopy to the study of plasma lipoprotein structure.

  1972cited by this paper
• The FASEB Journal • Research Communication Low density lipoprotein misfolding and amyloidogenesis

  year unknowncited by this paper

• Low-Density Lipoprotein Subfraction Phenotype Is Associated with Epicardial Adipose Tissue Volume in Type 2 Diabetes

  2025cites this paper
• Binding of human low-density lipoproteins to type-I collagen is synergistic with the pro-atherogenic lipoprotein remodeling.

  2025cites this paper
• Electronegative LDL strongly induces LRP1 release from human monocytes and macrophages.

  2025cites this paper
• Selective regulation of macrophage lipid metabolism via nanomaterials’ surface chemistry

  2024cites this paper
• Computational analysis of the alpha-2 domain of apolipoprotein B - 100, a potential triggering factor in LDL aggregation.

  2024cites this paper
• Can Electronegative LDL Act as a Multienzymatic Complex?

  2023cites this paper
• Thirty-Five-Year History of Desialylated Lipoproteins Discovered by Vladimir Tertov

  2022cites this paper
• Presence of Ceramidase Activity in Electronegative LDL

  2022cites this paper
• Targeting cholesteryl ester accumulation in the heart improves cardiac insulin response.

  2022cites this paper
• Aggregation Susceptibility of Low-Density Lipoproteins—A Novel Modifiable Biomarker of Cardiovascular Risk

  2021cites this paper
• Autoimmune Rheumatic Diseases: An Update on the Role of Atherogenic Electronegative LDL and Potential Therapeutic Strategies

  2021cites this paper
• Changes in the Composition and Function of Lipoproteins after Bariatric Surgery in Patients with Severe Obesity

  2021cites this paper
• Electronegative LDL Promotes Inflammation and Triglyceride Accumulation in Macrophages

  2020cites this paper
• Association of rheumatoid arthritis disease activity and antibodies to periodontal bacteria with serum lipoprotein profile in drug naive patients

  2020cites this paper
• Low-density lipoprotein aggregation is inhibited by apolipoprotein J-derived mimetic peptide D-[113-122]apoJ.

  2020cites this paper
• Neutrophils as a Novel Target of Modified Low-Density Lipoproteins and an Accelerator of Cardiovascular Diseases

  2020cites this paper
• Electronegative Low-density Lipoprotein (L5) may be Associated with the Severity of COVID-19

  2020cites this paper
• Why are cardiovascular diseases more common among patients with severe mental illness? The potential involvement of electronegative low-density lipoprotein (LDL) L5.

  2020cites this paper
• Sulfate-based lipids: Analysis of healthy human fluids and cell extracts.

  2019cites this paper
• Electronegative LDL: An Active Player in Atherogenesis or a By- Product of Atherosclerosis?

  2019cites this paper
• The effect of intakes of fish and Camelina sativa oil on atherogenic and anti-atherogenic functions of LDL and HDL particles: A randomized controlled trial.

  2019cites this paper
• Molecular basis for the protective effects of low-density lipoprotein receptor-related protein 1 (LRP1)-derived peptides against LDL aggregation.

  2019cites this paper
• Low‐density lipoprotein net charge is a risk factor for atherosclerosis in lupus patients independent of lipid concentrations

  2018cites this paper
• 21 Modified Forms of LDL in Plasma

  2018cites this paper
• Electronegative LDL induces MMP-9 and TIMP-1 release in monocytes through CD14 activation: Inhibitory effect of glycosaminoglycan sulodexide.

  2018cites this paper
• Structural stability and lipid interactions in the misfolding of human apolipoprotein A-I: what makes the protein amyloidogenic?

  2017cites this paper
• Lysosomal oxidation of Low Density Lipoproteins

  2017cites this paper
• Electronegative Low-Density Lipoprotein L5 Impairs Viability and NGF-Induced Neuronal Differentiation of PC12 Cells via LOX-1

  2017cites this paper
• Inflammatory intracellular pathways activated by electronegative LDL in monocytes.

  2016cites this paper
• Thermal stability of human plasma electronegative low-density lipoprotein: A paradoxical behavior of low-density lipoprotein aggregation.

  2016influential citation
• Enhanced Sphingomyelinase Activity Contributes to the Apoptotic Capacity of Electronegative Low-Density Lipoprotein.

  2016cites this paper
• The role of LDL-bound apoJ in the development of atherosclerosis

  2015cites this paper
• Amyloid-Forming Properties of Human Apolipoproteins: Sequence Analyses and Structural Insights.

  2015cites this paper
• Inhibitory effect of polyethylene oxide and polypropylene oxide triblock copolymers on aggregation and fusion of atherogenic low density lipoproteins

  2015cites this paper
• Hypoxia worsens the impact of intracellular triglyceride accumulation promoted by electronegative low-density lipoprotein in cardiomyocytes by impairing perilipin 5 upregulation.

  2015cites this paper
• Electronegative LDL induces priming and inflammasome activation leading to IL-1β release in human monocytes and macrophages.

  2015cites this paper
• Clusterin/apolipoprotein J binds to aggregated LDL in human plasma and plays a protective role against LDL aggregation

  2015cites this paper
• Mechanisms of cytokine release induced by electronegative LDL in monocytes. The role of ceramide and the receptors CD14-TLR4

  2014cites this paper
• Misfolding of apoprotein B-100, LDL aggregation and 17-β -estradiol in atherogenesis.

  2014cites this paper
• Ceramide-enriched LDL induces cytokine release through TLR4 and CD14 in monocytes. Similarities with electronegative LDL.

  2014cites this paper
• Electronegative LDL: A Circulating Modified LDL with a Role in Inflammation

  2013cites this paper
• The Induction of Cytokine Release in Monocytes by Electronegative Low-Density Lipoprotein (LDL) Is Related to Its Higher Ceramide Content than Native LDL

  2013cites this paper
• Aggregation and fusion of low-density lipoproteins in vivo and in vitro

  2013cites this paper
• Modified Forms of LDL in Plasma

  2012cites this paper
• Pluronic Block Copolymers Inhibit Low Density Lipoprotein Self-Association

  2012cites this paper
• Negatively charged L5 as a naturally occurring atherogenic low-density lipoprotein

  2012cites this paper
• Effects of Electronegative VLDL on Endothelium Damage in Metabolic Syndrome

  2012cites this paper
• Electronegative LDL: a useful biomarker of cardiovascular risk?

  2012cites this paper
• 1 Kinetic Analysis of Thermal Stability of Human Low-Density Lipoproteins : A Model for LDL Fusion in Atherogenesis 7 / 19 / 2012 Running title : Kinetic Stability and Fusion of LDL

  2012cites this paper
• Kinetic analysis of thermal stability of human low density lipoproteins: a model for LDL fusion in atherogenesis[S]

  2012cites this paper
• Electronegative low-density lipoprotein. A link between apolipoprotein B misfolding, lipoprotein aggregation and proteoglycan binding

  2012cites this paper
• Effects of phospholipase A2 and its products on structural stability of human LDL: relevance to formation of LDL-derived lipid droplets[S]

  2011cites this paper
• Chemical composition-oriented receptor selectivity of L5, a naturally occurring atherogenic low-density lipoprotein

  2011cites this paper
• Immunochemical Analysis of the Electronegative LDL Subfraction Shows That Abnormal N-terminal Apolipoprotein B Conformation Is Involved in Increased Binding to Proteoglycans*

  2010cites this paper
• Atherogenesis and aggregated electronegative LDL

  2010cites this paper
• "…an increased plasma proportion of LDL(-) could play a role in the enhanced systemic inflammation status underlying the pathogenesis of atherosclerosis."

  2010cites this paper